{"id":"https://openalex.org/W3045019727","doi":"https://doi.org/10.1016/j.ijpharm.2020.119685","title":"Human dental stem cells of the apical papilla associated to BDNF-loaded pharmacologically active microcarriers (PAMs) enhance locomotor function after spinal cord injury","display_name":"Human dental stem cells of the apical papilla associated to BDNF-loaded pharmacologically active microcarriers (PAMs) enhance locomotor function after spinal cord injury","publication_year":2020,"publication_date":"2020-07-23","ids":{"openalex":"https://openalex.org/W3045019727","doi":"https://doi.org/10.1016/j.ijpharm.2020.119685","mag":"3045019727","pmid":"https://pubmed.ncbi.nlm.nih.gov/32712253"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijpharm.2020.119685","doi":"https://doi.org/10.1016/j.ijpharm.2020.119685","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2020.119685","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S0378517320306694","source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/am/pii/S0378517320306694","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040597906","display_name":"Saikrishna Kandalam","orcid":"https://orcid.org/0009-0003-3451-0121","observed_orcids":["https://orcid.org/0009-0003-3451-0121"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210092509","display_name":"Centre de Recherche en Canc\u00e9rologie et Immunologie Int\u00e9gr\u00e9e Nantes Angers","ror":"https://ror.org/003g1aw90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509","https://openalex.org/I4210096427","https://openalex.org/I4210106090","https://openalex.org/I4210112910","https://openalex.org/I49451733","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I4405260337","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03kjmz544","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I49451733","display_name":"Universit\u00e9 d'Angers","ror":"https://ror.org/04yrqp957","country_code":"FR","type":"education","lineage":["https://openalex.org/I49451733"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["BE","FR"],"is_corresponding":false,"raw_author_name":"Saikrishna Kandalam","raw_affiliation_strings":["Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium; CRCINA, INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d'Angers, Angers F-49933, France","CRCINA-\u00c9QUIPE 17 - Design and Application of Innovative Local Treatments in Glioblastoma (France)","LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium; CRCINA, INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d'Angers, Angers F-49933, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4405260337","https://openalex.org/I49451733","https://openalex.org/I95674353","https://openalex.org/I97188460"]},{"raw_affiliation_string":"CRCINA-\u00c9QUIPE 17 - Design and Application of Innovative Local Treatments in Glioblastoma (France)","institution_ids":["https://openalex.org/I4210092509"]},{"raw_affiliation_string":"LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011729608","display_name":"Pauline De Berdt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Pauline De Berdt","raw_affiliation_strings":["Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium","LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium","institution_ids":["https://openalex.org/I95674353"]},{"raw_affiliation_string":"LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040828807","display_name":"Bernard U\u010dakar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Bernard Ucakar","raw_affiliation_strings":["Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium","LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium","institution_ids":["https://openalex.org/I95674353"]},{"raw_affiliation_string":"LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057668117","display_name":"K\u00e9vin Vanvarenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Kevin Vanvarenberg","raw_affiliation_strings":["Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium","LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium","institution_ids":["https://openalex.org/I95674353"]},{"raw_affiliation_string":"LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039129582","display_name":"Caroline Bouzin","orcid":"https://orcid.org/0000-0003-0694-1947","observed_orcids":["https://orcid.org/0000-0003-0694-1947"]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Caroline Bouzin","raw_affiliation_strings":["IREC Imaging platform (2IP), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain, UCLouvain, IREC, 1200 Brussels, Belgium","IREC - Institut de Recherche Exp\u00e9rimentale et Clinique (Pole of Pharmacology and Therapeutics (FATH), 1 Place de l'Universit\u00e9 B-1348 Louvain-la-Neuve, Bruxelles - Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IREC Imaging platform (2IP), Institut de Recherche Exp\u00e9rimentale et Clinique (IREC), Universit\u00e9 Catholique de Louvain, UCLouvain, IREC, 1200 Brussels, Belgium","institution_ids":["https://openalex.org/I95674353"]},{"raw_affiliation_string":"IREC - Institut de Recherche Exp\u00e9rimentale et Clinique (Pole of Pharmacology and Therapeutics (FATH), 1 Place de l'Universit\u00e9 B-1348 Louvain-la-Neuve, Bruxelles - Belgium)","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063204153","display_name":"Viridiane Gratpain","orcid":"https://orcid.org/0000-0003-0731-0602","observed_orcids":["https://orcid.org/0000-0003-0731-0602"]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Viridiane Gratpain","raw_affiliation_strings":["Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium","LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium","institution_ids":["https://openalex.org/I95674353"]},{"raw_affiliation_string":"LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086811949","display_name":"Anibal R. Diogenes","orcid":"https://orcid.org/0000-0001-5081-8060","observed_orcids":["https://orcid.org/0000-0001-5081-8060"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I45438204","display_name":"The University of Texas at San Antonio","ror":"https://ror.org/01kd65564","country_code":"US","type":"education","lineage":["https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anibal Diogenes","raw_affiliation_strings":["Department of Endodontics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA","UTSA - The University of Texas at San Antonio (1 UTSA Circle, San Antonio, TX 78249 - United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endodontics, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA","institution_ids":["https://openalex.org/I165951966"]},{"raw_affiliation_string":"UTSA - The University of Texas at San Antonio (1 UTSA Circle, San Antonio, TX 78249 - United States)","institution_ids":["https://openalex.org/I45438204"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079373121","display_name":"Claudia N. Montero\u2010Menei","orcid":"https://orcid.org/0000-0002-1373-6987","observed_orcids":["https://orcid.org/0000-0002-1373-6987"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210092509","display_name":"Centre de Recherche en Canc\u00e9rologie et Immunologie Int\u00e9gr\u00e9e Nantes Angers","ror":"https://ror.org/003g1aw90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509","https://openalex.org/I4210096427","https://openalex.org/I4210106090","https://openalex.org/I4210112910","https://openalex.org/I49451733","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I4405260337","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03kjmz544","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I49451733","display_name":"Universit\u00e9 d'Angers","ror":"https://ror.org/04yrqp957","country_code":"FR","type":"education","lineage":["https://openalex.org/I49451733"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Claudia N. Montero-Menei","raw_affiliation_strings":["CRCINA, INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d'Angers, Angers F-49933, France. Electronic address: claudia.montero-menei@univ-angers.fr","CRCINA-\u00c9QUIPE 17 - Design and Application of Innovative Local Treatments in Glioblastoma (France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRCINA, INSERM, Universit\u00e9 de Nantes, Universit\u00e9 d'Angers, Angers F-49933, France. Electronic address: claudia.montero-menei@univ-angers.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210092509","https://openalex.org/I4405260337","https://openalex.org/I49451733","https://openalex.org/I97188460"]},{"raw_affiliation_string":"CRCINA-\u00c9QUIPE 17 - Design and Application of Innovative Local Treatments in Glioblastoma (France)","institution_ids":["https://openalex.org/I4210092509"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073045144","display_name":"Anne des Rieux","orcid":"https://orcid.org/0000-0001-9953-3816","observed_orcids":["https://orcid.org/0000-0001-9953-3816"]},"institutions":[{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Anne des Rieux","raw_affiliation_strings":["Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium. Electronic address: anne.desrieux@uclouvain.be","LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)"],"raw_orcid":"https://orcid.org/0000-0001-9953-3816","affiliations":[{"raw_affiliation_string":"Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Universit\u00e9 Catholique de Louvain, UCLouvain, 1200 Bruxelles, Belgium. Electronic address: anne.desrieux@uclouvain.be","institution_ids":["https://openalex.org/I95674353"]},{"raw_affiliation_string":"LDRI - Louvain Drug Research Institute [Bruxelles, Belgique] (Belgium)","institution_ids":["https://openalex.org/I95674353"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5073045144","https://openalex.org/A5079373121"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210092509","https://openalex.org/I4405260337","https://openalex.org/I49451733","https://openalex.org/I95674353","https://openalex.org/I97188460"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":{"value":4650,"currency":"USD","value_usd":4650},"fwci":1.7784,"has_fulltext":true,"cited_by_count":23,"citation_normalized_percentile":{"value":0.86562753,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"587","issue":null,"first_page":"119685","last_page":"119685"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10925","display_name":"Spinal Cord Injury Research","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10925","display_name":"Spinal Cord Injury Research","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10483","display_name":"Nerve injury and regeneration","score":0.04280000180006027,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10176","display_name":"Mesenchymal stem cell research","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spinal-cord-injury","display_name":"spinal cord injury","score":0.8619999885559082},{"id":"https://openalex.org/keywords/stem-cells-from-apical-papilla","display_name":"stem cells from apical papilla","score":0.8679999709129333},{"id":"https://openalex.org/keywords/dental-stem-cells","display_name":"dental stem cells","score":0.859000027179718},{"id":"https://openalex.org/keywords/brain-derived-neurotrophic-factor","display_name":"brain-derived neurotrophic factor","score":0.9599999785423279},{"id":"https://openalex.org/keywords/mesenchymal-stem-cells","display_name":"mesenchymal stem cells","score":0.7860000133514404},{"id":"https://openalex.org/keywords/locomotor-function","display_name":"locomotor function","score":0.7770000100135803},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.8730000257492065},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9990000128746033},{"id":"https://openalex.org/keywords/axon-growth","display_name":"axon growth","score":0.6639999747276306},{"id":"https://openalex.org/keywords/plga-nanoparticles","display_name":"PLGA nanoparticles","score":0.7039999961853027},{"id":"https://openalex.org/keywords/fibronectin-coating","display_name":"fibronectin coating","score":0.9240000247955322},{"id":"https://openalex.org/keywords/spinal-cord-contusion","display_name":"spinal cord contusion","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.7563465237617493},{"id":"https://openalex.org/C2778334475","wikidata":"https://www.wikidata.org/wiki/Q1415275","display_name":"Spinal cord injury","level":3,"score":0.6817584037780762},{"id":"https://openalex.org/C160539049","wikidata":"https://www.wikidata.org/wiki/Q3064187","display_name":"Neurotrophic factors","level":3,"score":0.617466926574707},{"id":"https://openalex.org/C2778790584","wikidata":"https://www.wikidata.org/wiki/Q123045","display_name":"Brain-derived neurotrophic factor","level":4,"score":0.4853000044822693},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4831047058105469},{"id":"https://openalex.org/C198826908","wikidata":"https://www.wikidata.org/wiki/Q1922379","display_name":"Mesenchymal stem cell","level":2,"score":0.45953842997550964},{"id":"https://openalex.org/C136834591","wikidata":"https://www.wikidata.org/wiki/Q2944097","display_name":"Neural stem cell","level":3,"score":0.4512268602848053},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.4360673427581787},{"id":"https://openalex.org/C2780775167","wikidata":"https://www.wikidata.org/wiki/Q9606","display_name":"Spinal cord","level":2,"score":0.3891395330429077},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37541908025741577},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.336943119764328},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.237665593624115},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.20784661173820496},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20670649409294128},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15253859758377075},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013116","descriptor_name":"Spinal Cord","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013119","descriptor_name":"Spinal Cord Injuries","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019208","descriptor_name":"Brain-Derived Neurotrophic Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059630","descriptor_name":"Mesenchymal Stem Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ijpharm.2020.119685","doi":"https://doi.org/10.1016/j.ijpharm.2020.119685","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2020.119685","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S0378517320306694","source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:32712253","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32712253","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-03491585v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-03491585","pdf_url":"https://hal.science/hal-03491585v1/file/S0378517320306694.pdf","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics, 2020, 587, pp.119685 -. ⟨10.1016/j.ijpharm.2020.119685⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:243159","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2078.1/243159","pdf_url":null,"source":{"id":"https://openalex.org/S4306401902","display_name":"Digital Access to Libraries (Universit\u00e9 catholique de Louvain (UCL), l'Universit\u00e9 de Namur (UNamur) and the Universit\u00e9 Saint-Louis (USL-B))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I95674353","host_organization_name":"UCLouvain","host_organization_lineage":["https://openalex.org/I95674353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International journal of pharmaceutics, Vol. 587, p. 119685 (2020)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.ijpharm.2020.119685","doi":"https://doi.org/10.1016/j.ijpharm.2020.119685","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijpharm.2020.119685","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S0378517320306694","source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320320921","display_name":"International Foundation for Research in Paraplegia","ror":"https://ror.org/04hhnrj18"},{"id":"https://openalex.org/F4320321390","display_name":"Fonds De La Recherche Scientifique - FNRS","ror":"https://ror.org/03q83t159"},{"id":"https://openalex.org/F4320327974","display_name":"Conseil R\u00e9gional des Pays de la Loire","ror":"https://ror.org/01zsm1k25"},{"id":"https://openalex.org/F4320334680","display_name":"Education, Audiovisual and Culture Executive Agency","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3045019727.pdf","grobid_xml":"https://content.openalex.org/works/W3045019727.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1813889356","https://openalex.org/W1981314894","https://openalex.org/W1988169163","https://openalex.org/W1992218960","https://openalex.org/W1996512453","https://openalex.org/W2006861443","https://openalex.org/W2007402666","https://openalex.org/W2015130593","https://openalex.org/W2018741703","https://openalex.org/W2031484603","https://openalex.org/W2042377063","https://openalex.org/W2052565165","https://openalex.org/W2061954426","https://openalex.org/W2076053456","https://openalex.org/W2081490291","https://openalex.org/W2110804473","https://openalex.org/W2125781027","https://openalex.org/W2144312385","https://openalex.org/W2145040826","https://openalex.org/W2152459707","https://openalex.org/W2156019550","https://openalex.org/W2165985696","https://openalex.org/W2169663632","https://openalex.org/W2170645579","https://openalex.org/W2199220969","https://openalex.org/W2234834148","https://openalex.org/W2279353265","https://openalex.org/W2407008898","https://openalex.org/W2549849720","https://openalex.org/W2567116115","https://openalex.org/W2574408006","https://openalex.org/W2751752032","https://openalex.org/W2788995220","https://openalex.org/W2801516460","https://openalex.org/W2804103364","https://openalex.org/W2948232419","https://openalex.org/W2990758172","https://openalex.org/W3002946912"],"related_works":["https://openalex.org/W2234328577","https://openalex.org/W4224251786","https://openalex.org/W1813889356","https://openalex.org/W2797062639","https://openalex.org/W2156895150","https://openalex.org/W3176295210","https://openalex.org/W2362539731","https://openalex.org/W2890255223","https://openalex.org/W2889559822","https://openalex.org/W2360382214"],"abstract_inverted_index":{"There":[0],"is":[1,16],"no":[2],"treatment":[3],"for":[4,193],"spinal":[5,108],"cord":[6,109],"injury":[7],"(SCI)":[8],"that":[9,37,199],"fully":[10],"repairs":[11],"the":[12,23,38,45,139,152,160,169,180,202,210],"damages.":[13],"One":[14],"strategy":[15],"to":[17,25],"inject":[18],"mesenchymal":[19],"stem":[20,42],"cells":[21,43],"around":[22],"lesion":[24,153],"benefit":[26],"from":[27,44],"their":[28,113],"immunomodulatory":[29,95,142],"properties":[30],"and":[31,66,76,79,94,112,121,128,144,167,175,182,189],"neuroprotective":[32],"effect.":[33],"Our":[34],"hypothesis":[35],"was":[36,97,116,131],"combination":[39],"of":[40,74,92,141,148,162,171,184,207,212],"dental":[41],"apical":[46],"papilla":[47],"(SCAP)":[48],"with":[49,82],"pharmacologically":[50],"active":[51],"microcarriers":[52],"(PAMs)":[53],"releasing":[54],"brain-derived":[55],"neurotrophic":[56],"factor":[57],"(BDNF)":[58],"would":[59],"improve":[60],"rat":[61,107,156],"locomotor":[62,114],"function":[63,115],"by":[64,71,118,133],"immunomodulation":[65],"neuroprotection.":[67],"BDNF-PAMs":[68,102,150,200],"were":[69,85,103],"prepared":[70],"solid/oil/water":[72],"emulsion":[73],"poly(L-lactide-co-glycolide)":[75],"nanoprecipitated":[77],"BDNF":[78],"subsequent":[80],"coating":[81],"fibronectin.":[83],"SCAP":[84,90,101,149,208],"then":[86],"seeded":[87],"on":[88,126,136],"BDNF-PAMs.":[89],"expression":[91,161,170],"neuronal":[93],"factors":[96],"evaluated":[98,117,132],"in":[99,105,209],"vitro.":[100],"injected":[104],"a":[106],"contusion":[110],"model":[111],"Basso,":[119],"Beattie,":[120],"Bresnahan":[122],"(BBB)":[123],"scoring.":[124],"Impact":[125],"inflammation":[127],"neuroprotection/axonal":[129],"growth":[130],"immunofluorescence.":[134],"Culture":[135],"PAMs":[137,185],"induced":[138],"overexpression":[140],"molecules":[143],"neural/neuronal":[145],"markers.":[146],"Injection":[147],"at":[151],"site":[154],"improved":[155],"BBB":[157],"scoring,":[158],"reduced":[159],"inducible":[163],"nitric":[164],"oxide":[165],"synthase":[166],"increased":[168],"\u03b2III":[172],"tubulin,":[173],"GAP43,":[174],"5-HT.":[176],"These":[177],"results":[178],"confirm":[179],"suitability":[181],"versatility":[183],"as":[186],"combined":[187],"drug":[188],"cell":[190],"delivery":[191],"system":[192],"regenerative":[194],"medicine":[195],"applications":[196],"but":[197],"also":[198],"potentialize":[201],"very":[203],"promising":[204],"therapeutic":[205],"potential":[206],"scope":[211],"SCI.":[213]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-07-29T00:00:00"}